Anixa Biosciences, Inc

(NASDAQ:ANIX)

Latest On Anixa Biosciences, Inc (ANIX):

Date/Time Type Description Signal Details
2023-04-18 20:27 ESTNewsAnixa: I Am More Bullish After Efficacy Data For Its Triple-Negative Breast Cancer VaccineN/A
2022-08-16 04:17 ESTNewsAnixa adds 11% after dosing initiation in CAR-T ovarian cancer trialN/A
2022-07-22 11:56 ESTNewsAnixa to get additional US patent linked to breast cancer vaccine technologyN/A
2022-05-27 00:36 ESTNewsAnixa Biosciences (ANIX) Investor Presentation - SlideshowN/A
2022-05-11 18:58 ESTNewsAnixa: Making Sense Of A Bullish Move Up In Bearish Biotech TimesN/A
2022-03-31 06:50 ESTNewsAnixa Biosciences initiates phase 1 trial of its ovarian cancer CAR-T therapyN/A
2022-01-24 16:54 ESTNewsAnixa says new protease inhibitor outperformed main agent in Pfizer’s COVID-19 pillN/A
2021-12-08 02:14 ESTNewsAnixa Bio says its COVID-19 compounds are expected to be effective against Omicron variantN/A
2021-10-26 12:03 ESTNewsAnixa Biosciences gets dosing underway in breast cancer vaccine studyN/A
2021-10-19 05:32 ESTNewsWarning: ANIX is at high risk of performing badlyN/A
2021-10-07 04:24 ESTNewsAnixa Biosciences nabs first Chinese patent for CAR-T cancer therapy technologyN/A
2021-10-02 06:19 ESTNewsAnixa Biosciences gets notice of allowance for additional patent on its CAR-T cancer therapyN/A
2021-10-02 06:19 ESTNewsAnixa Bio nabs new U.S. patent for its CAR-T cancer therapy (duplicate)N/A
2021-09-23 22:45 ESTNewsOur First Look At Anixa BiosciencesN/A
2021-08-31 03:17 ESTNewsAnixa Bio gets FDA green light to initiate trial of ovarian cancer CAR-T immunotherapyN/A
2021-08-25 12:46 ESTNewsAnixa Biosciences' COVID-19 compounds show promise against Delta variantN/A
2021-04-20 01:13 ESTNewsAnixa Biosciences places CAR-T therapy study on holdN/A
2021-04-12 15:59 ESTNewsTwist Bioscience and Codexis in focus as Piper Sandler upbeat on synthetic biology, and more in today’s analyst actionN/A
2021-04-05 22:51 ESTNewsAnixa advancing COVID-19 antiviral candidates to preclinical stageN/A
2021-03-23 18:58 ESTNewsAnixa Biosciences plunges on upsizing stock offering to $22.5MN/A
2021-03-22 22:28 ESTNewsAnixa Biosciences to raise $10M in bought deal offeringN/A
2021-03-15 08:06 ESTEarnings EstimateAn EPS average of -$0.14 is estimated for the quarter ending on July 31, 2021.Sell
2021-03-12 20:16 ESTNewsAnixa Bio shares surge 35% on European patent for ovarian cancer vaccine technologyN/A
2021-03-12 07:07 ESTFinancialsCompany financials have been released.Neutral
2021-03-04 17:31 ESTNewsAnixa issued European patent for CAR-T cancer therapyN/A
2021-01-11 07:07 ESTEarnings EstimateAn EPS average of -$0.59 is estimated for the 2022 year.Sell
2021-01-11 07:07 ESTEarnings EstimateAn EPS average of -$0.12 is estimated for the quarter ending on April 30, 2021.Sell
2021-01-09 11:06 ESTFinancialsCompany financials have been released.Neutral
2020-12-13 03:11 ESTFinancialsCompany financials have been released.Neutral
2020-12-02 15:59 ESTNewsAnixa Biosciences, Cleveland Clinic in ovarian cancer vaccine pactN/A
2020-11-15 11:10 ESTFinancialsCompany financials have been released.Neutral
2020-11-01 17:02 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 04:13 ESTFinancialsCompany financials have been released.Neutral
2020-09-14 09:46 ESTInsider TradeLewis H jr Titterton has directly acquired 40,000 shares and currently holds 1,020,326 shares.Buy
2020-09-11 12:15 ESTInsider TradeAMIT KUMAR has directly acquired 28,000 shares and currently holds 262,000 shares.Buy
2020-09-11 12:06 ESTFinancialsCompany financials have been released.Neutral
2020-09-10 12:06 ESTFinancialsCompany financials have been released.Neutral
2020-09-10 04:06 ESTEarnings EstimateAn EPS average of -$0.13 is estimated for the quarter ending on January 31, 2021.Sell
2020-07-31 00:09 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 12:06 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 16:14 ESTFinancialsCompany financials have been released.Neutral
2020-07-13 04:08 ESTAnalyst RatingThe Analyst Target Price has increased from $8.25 to $8.75.Buy
2020-07-11 07:58 ESTNewsAnixa nabs European patent covering CAR-T technologyN/A
2020-07-07 02:28 ESTNewsAnixa and OntoChem identify potential COVID-19 candidatesN/A
2020-07-03 04:13 ESTNewsAnixa realigns with focus on its therapeutic and vaccine PipelineN/A
2020-06-17 11:01 ESTInsider TradeLewis H jr Titterton has directly acquired 24,500 shares and currently holds 980,326 shares.Buy
2020-06-16 11:46 ESTInsider TradeLewis H jr Titterton has directly acquired 31,083 shares and currently holds 955,826 shares.Buy
2020-06-12 11:01 ESTInsider TradeAMIT KUMAR has directly acquired 20,000 shares and currently holds 234,000 shares.Buy
2020-06-12 04:07 ESTFinancialsCompany financials have been released.Neutral
2020-06-01 18:51 ESTNewsAnixa rallies on development of four COVID-19 candidatesN/A

About Anixa Biosciences, Inc (ANIX):

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain viral protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with OntoChem GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was founded in 1982 and is based in San Jose, California.

ANIX Quotes by TradingView

See Advanced Chart

General

  • Name Anixa Biosciences, Inc
  • Symbol ANIX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDiagnostics & Research
  • Full Time Employees 3
  • Last Split Factor1:1
  • Last Split Date2016-10-18
  • Fiscal Year EndOctober
  • IPO Date1987-01-01
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.anixa.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 152.51
  • Price/Book (Most Recent Quarter) 15.06
  • Enterprise Value Revenue 136.42
View More

Financials

  • Most Recent Quarter 2021-01-31
  • Current Year EPS Estimate -$0.50
  • Next Year EPS Estimate -$0.60
  • Operating Margin -1804%
  • Return on Assets -56%
  • Return on Equity -107%
  • Revenue 512500
  • Earnings Per Share -$0.77
  • Revenue Per Share $0.02
  • Gross Profit 83750
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 186.67 million
  • EBITDA -13628274
  • Analyst Target Price $8.75
  • Book Value Per Share $0.52
View More

Share Statistics

  • Shares Outstanding 26.71 million
  • Shares Float 25.51 million
  • % Held by Insiders 596%
  • % Held by Institutions 7.72%
  • Shares Short 497679
  • Shares Short Prior Month 479168
  • Short Ratio 1.39
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 1.57
  • 52 Week High $8.09
  • 52 Week Low $1.33
  • 50 Day Moving Average 4.98
  • 200 Day Moving Average 3.26
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Anixa Biosciences, Inc (ANIX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Anixa Biosciences, Inc (ANIX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2021-01-312021-03-11$512500-$0.07-$0.1236.96%
2020-10-312021-01-07$N/A-$0.09-$0.1118.18%
2020-07-312020-09-08$N/A-$0.11-$0.128.33%
2020-04-302020-06-09$N/A-$0.12-$0.137.69%
2020-01-312020-03-09$N/A-$0.13-$0.130%
2019-10-312020-01-09$N/A-$0.10-$0.2458.33%
2019-07-312019-09-06$N/A-$0.11-$0.2352.17%
2019-04-302019-06-12$250000-$0.13-$0.2343.48%
2019-01-312019-03-13$N/A-$0.23-$0.15-55.2%
2018-10-312019-01-11$-362500-$0.26-$0.15-74.07%
2018-07-312018-09-07$362500-$0.30
2018-04-302018-06-11$750000-$0.08
2018-01-312018-03-09$N/A-$0.11
2017-10-312018-01-09$-500-$0.11
2017-07-312017-09-08$363000-$0.12
2017-04-302017-05-26$N/A$0.02
2017-01-312017-03-16$N/A-$0.41
2016-10-312016-12-07$200000-$0.12
2016-07-312016-08-19$100000-$0.13
2016-04-302016-05-20$N/A-$0.15
2016-01-312016-03-08$N/A-$0.18
2015-10-312015-12-30$160000-$0.15
2015-07-312015-09-15$95000-$0.18
2015-04-302015-05-22$25000-$0.26
2015-01-312015-03-10$9.14 million$0.41
2014-10-312015-01-29$1.38 million-$0.36
2014-07-312014-09-16$1.19 million$0.05
2014-04-302014-06-16$1.11 million-$0.38
2014-01-312014-03-18$N/A-$0.43
2013-10-312014-01-14$389000-$0.35
2013-04-302013-06-10$N/A-$0.32
2013-01-312013-03-19$2130-$0.28
2012-10-312013-01-15$-127150-$0.26
2012-07-312012-09-11$250000-$0.09
2012-04-302012-06-11$248000-$0.12
2012-01-312012-03-20$449000-$0.12
2011-10-312012-01-17$449000-$0.42
2011-07-312011-09-13$450000-$0.26
2011-04-302011-06-13$87000-$0.19
2011-01-312011-03-22$17000-$0.24
2010-10-312011-01-18$312000-$0.19
2010-07-312010-09-14$58000-$0.21
2010-04-302010-06-14$322000-$0.22
2010-01-312010-03-23$39000-$0.26
2009-10-312010-01-12$119000-$2.25
2009-07-312009-09-10$300000-$0.21
2009-04-302009-06-19$263000-$0.24
2009-01-312009-03-17$374000-$0.26
2008-10-312009-01-13$963000-$0.25
2008-07-312008-09-15$882000-$0.14
2008-04-302008-06-13$166000-$0.36
2008-01-312008-03-18$52000-$0.53
2007-10-312008-01-15$146000-$0.29
2007-07-312007-09-17$114000-$0.25
2007-04-302007-04-30$96000-$0.35
2007-01-312007-01-31$131000-$0.44
2006-10-312006-10-31$111000-$0.50
2006-07-312006-07-31$131000-$0.56
2006-04-302006-04-30$72000-$0.64
2006-01-312006-01-31$195000-$0.33
2005-10-312005-10-31$49000-$0.32
2005-07-312005-07-31$132000-$0.31
2005-04-302005-04-30$46000-$0.34
2005-01-312005-01-31$213000-$0.29
2004-10-312004-10-31$137000-$0.25
2004-07-312004-07-31$216000-$0.31
2004-04-302004-04-30$102000-$0.21
2004-01-312004-01-31$39000-$0.25
2003-10-312003-10-31$48000-$0.23
2003-07-312003-07-31$83000-$0.21
2003-04-302003-04-30$22000-$0.33
2003-01-312003-01-31$91000-$0.28
2002-07-312002-07-31$1.25 million-$1.11
2002-04-302002-04-30$2.62 million$0.33
2002-01-312002-01-31$1.28 million$0.02
2001-07-312001-07-31$516000-$0.36
2001-04-302001-04-30$245000-$0.31
2001-01-312001-01-31$178000-$0.45
2000-07-312000-07-31$493000-$0.39
2000-04-302000-04-30$421000-$0.50
2000-01-312000-01-31$277000-$0.55
1999-07-311999-07-31-$0.80
1999-04-301999-04-30-$0.68
1999-01-311999-01-31-$0.62
1998-07-311998-07-31-$0.73
1998-04-301998-04-30-$0.78
1998-01-311998-01-31-$0.84

Anixa Biosciences, Inc (ANIX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Anixa Biosciences, Inc (ANIX) Chart:

Anixa Biosciences, Inc (ANIX) News:

Below you will find a list of latest news for Anixa Biosciences, Inc (ANIX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Anixa Biosciences, Inc (ANIX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50.75CALL0 130119.86TRUE00
2024-05-1750.05CALL0 420FALSE00
2024-05-177.50CALL0 00FALSE00
2024-05-172.50.1PUT0 170FALSE00
2024-05-1750PUT0 0115.11TRUE00
2024-05-177.50PUT0 0379.11TRUE00
2024-06-212.50CALL0 00TRUE00
2024-06-2151.3CALL2 0348.09FALSE1.30
2024-06-217.50CALL0 00FALSE00
2024-06-212.50PUT0 00FALSE00
2024-06-2150PUT0 0225.86TRUE00
2024-06-217.50PUT0 00TRUE00
2024-07-192.51CALL0 895111.23TRUE00
2024-07-1950.2CALL0 5150FALSE00
2024-07-197.50.13CALL0 1530FALSE00
2024-07-192.50.3PUT0 2486.66FALSE00
2024-07-1951.22PUT0 071.5TRUE00
2024-07-197.50PUT0 0139.1TRUE00
2024-10-182.51.2CALL0 520119.92TRUE00
2024-10-1850.45CALL11 20103.62FALSE0.450
2024-10-187.50.5CALL0 220FALSE00
2024-10-182.50.3PUT0 50106.91FALSE00
2024-10-1852.2PUT0 597.53TRUE00
2024-10-187.50PUT0 00TRUE00

Latest ANIX Trades:

Date Shares Price
Jun 13, 2022 3:05 PM EST100$3.32
Jun 13, 2022 1:36 PM EST100$3.45
Jun 13, 2022 7:46 PM EST100$3.18

Anixa Biosciences, Inc (ANIX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-02DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000137/0001513162-20-000137-index.htm
2019-06-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/715446/000000000019009951/0000000000-19-009951-index.htm
2018-01-30SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/715446/000114420418004436/0001144204-18-004436-index.htm
2018-01-30SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/715446/000114420418004468/0001144204-18-004468-index.htm
2020-09-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/715446/000149315220017421/0001493152-20-017421-index.htm
2020-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000149315220017605/0001493152-20-017605-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000149315220017705/0001493152-20-017705-index.htm
2020-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000149315220017875/0001493152-20-017875-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000149315220020408/0001493152-20-020408-index.htm
2017-11-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316217000313/0001513162-17-000313-index.htm
2017-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316217000322/0001513162-17-000322-index.htm
2018-01-0910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/715446/000151316218000006/0001513162-18-000006-index.htm
2018-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316218000022/0001513162-18-000022-index.htm
2018-01-26PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000036/0001513162-18-000036-index.htm
2018-02-12DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000040/0001513162-18-000040-index.htm
2018-02-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000045/0001513162-18-000045-index.htm
2018-02-15SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/715446/000151316218000050/0001513162-18-000050-index.htm
2018-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316218000056/0001513162-18-000056-index.htm
2018-03-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/715446/000151316218000062/0001513162-18-000062-index.htm
2018-03-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/715446/000151316218000074/0001513162-18-000074-index.htm
2018-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316218000075/0001513162-18-000075-index.htm
2018-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316218000088/0001513162-18-000088-index.htm
2018-04-11144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000094/0001513162-18-000094-index.htm
2018-04-114/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000095/0001513162-18-000095-index.htm
2018-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000096/0001513162-18-000096-index.htm
2018-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316218000121/0001513162-18-000121-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000124/0001513162-18-000124-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000125/0001513162-18-000125-index.htm
2018-06-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/715446/000151316218000161/0001513162-18-000161-index.htm
2018-07-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000171/0001513162-18-000171-index.htm
2018-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316218000172/0001513162-18-000172-index.htm
2018-08-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000211/0001513162-18-000211-index.htm
2018-09-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/715446/000151316218000230/0001513162-18-000230-index.htm
2018-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000231/0001513162-18-000231-index.htm
2018-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000232/0001513162-18-000232-index.htm
2018-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000233/0001513162-18-000233-index.htm
2018-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000234/0001513162-18-000234-index.htm
2018-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000235/0001513162-18-000235-index.htm
2018-09-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000238/0001513162-18-000238-index.htm
2018-09-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316218000240/0001513162-18-000240-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316218000247/0001513162-18-000247-index.htm
2018-10-01S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000248/0001513162-18-000248-index.htm
2018-10-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000249/0001513162-18-000249-index.htm
2018-10-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000250/0001513162-18-000250-index.htm
2018-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000253/0001513162-18-000253-index.htm
2018-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000254/0001513162-18-000254-index.htm
2018-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000255/0001513162-18-000255-index.htm
2018-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000267/0001513162-18-000267-index.htm
2018-10-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316218000269/0001513162-18-000269-index.htm
2019-01-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/715446/000151316219000013/0001513162-19-000013-index.htm
2019-01-1110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/715446/000151316219000016/0001513162-19-000016-index.htm
2019-01-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316219000029/0001513162-19-000029-index.htm
2019-03-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/715446/000151316219000075/0001513162-19-000075-index.htm
2019-04-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000110/0001513162-19-000110-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000111/0001513162-19-000111-index.htm
2019-04-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000113/0001513162-19-000113-index.htm
2019-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000114/0001513162-19-000114-index.htm
2019-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000115/0001513162-19-000115-index.htm
2019-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000116/0001513162-19-000116-index.htm
2019-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000117/0001513162-19-000117-index.htm
2019-05-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316219000133/0001513162-19-000133-index.htm
2019-06-11S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/715446/000151316219000150/0001513162-19-000150-index.htm
2019-06-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/715446/000151316219000156/0001513162-19-000156-index.htm
2019-06-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/715446/000151316219000158/0001513162-19-000158-index.htm
2019-07-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316219000164/0001513162-19-000164-index.htm
2019-08-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316219000185/0001513162-19-000185-index.htm
2019-08-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316219000191/0001513162-19-000191-index.htm
2019-09-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/715446/000151316219000202/0001513162-19-000202-index.htm
2019-09-12DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000205/0001513162-19-000205-index.htm
2019-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000206/0001513162-19-000206-index.htm
2019-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000207/0001513162-19-000207-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000209/0001513162-19-000209-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000210/0001513162-19-000210-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000212/0001513162-19-000212-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000213/0001513162-19-000213-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000214/0001513162-19-000214-index.htm
2019-10-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316219000221/0001513162-19-000221-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000222/0001513162-19-000222-index.htm
2019-10-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000223/0001513162-19-000223-index.htm
2019-10-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000224/0001513162-19-000224-index.htm
2019-10-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000225/0001513162-19-000225-index.htm
2019-10-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000226/0001513162-19-000226-index.htm
2019-10-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000227/0001513162-19-000227-index.htm
2019-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000230/0001513162-19-000230-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000249/0001513162-19-000249-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316219000250/0001513162-19-000250-index.htm
2020-01-0910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/715446/000151316220000009/0001513162-20-000009-index.htm
2020-01-09424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/715446/000151316220000010/0001513162-20-000010-index.htm
2020-01-1010-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/715446/000151316220000012/0001513162-20-000012-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000015/0001513162-20-000015-index.htm
2020-01-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000018/0001513162-20-000018-index.htm
2020-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000019/0001513162-20-000019-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000022/0001513162-20-000022-index.htm
2020-03-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/715446/000151316220000040/0001513162-20-000040-index.htm
2020-03-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000042/0001513162-20-000042-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000047/0001513162-20-000047-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000048/0001513162-20-000048-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000054/0001513162-20-000054-index.htm
2020-04-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316220000088/0001513162-20-000088-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000092/0001513162-20-000092-index.htm
2020-06-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/715446/000151316220000122/0001513162-20-000122-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000123/0001513162-20-000123-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000124/0001513162-20-000124-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000127/0001513162-20-000127-index.htm
2020-06-22PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000129/0001513162-20-000129-index.htm
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316220000136/0001513162-20-000136-index.htm
2020-07-02DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000137/0001513162-20-000137-index.htm
2020-07-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/715446/000151316220000141/0001513162-20-000141-index.htm
2020-08-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/715446/000151316220000167/0001513162-20-000167-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000170/0001513162-20-000170-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000171/0001513162-20-000171-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000172/0001513162-20-000172-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000174/0001513162-20-000174-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/715446/000151316220000175/0001513162-20-000175-index.htm
2019-06-21EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/715446/999999999519001410/9999999995-19-001410-index.htm
2018-02-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/715446/999999999718000840/9999999997-18-000840-index.htm

Anixa Biosciences, Inc (ANIX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Anixa Biosciences, Inc (ANIX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 596%
Institutional Ownership: 772%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-09-11Lewis H jr TittertonDirectorBuy40,000.002.0883,200.001,020,326.00https://www.sec.gov/Archives/edgar/data/715446/000149315220017705/0001493152-20-017705-index.htm
2019-04-26Arnold M BaskiesDirectorBuy10,000.004.2842,800.0011,000.00https://www.sec.gov/Archives/edgar/data/715446/000151316219000113/0001513162-19-000113-index.htm
2018-09-12AMIT KUMARChief Executive OfficerBuy4,480.003.9917,875.20128,888.00https://www.sec.gov/Archives/edgar/data/715446/000151316218000231/0001513162-18-000231-index.htm
2018-09-13AMIT KUMARChief Executive OfficerBuy4,112.003.9616,283.52133,000.00https://www.sec.gov/Archives/edgar/data/715446/000151316218000232/0001513162-18-000232-index.htm
2018-09-13AMIT KUMARChief Executive OfficerBuy3,000.003.8411,520.00136,000.00https://www.sec.gov/Archives/edgar/data/715446/000151316218000233/0001513162-18-000233-index.htm
2018-09-14AMIT KUMARChief Executive OfficerBuy3,000.004.0812,240.00139,000.00https://www.sec.gov/Archives/edgar/data/715446/000151316218000235/0001513162-18-000235-index.htm
2018-10-25AMIT KUMARChief Executive OfficerBuy11,000.003.9042,900.00150,000.00https://www.sec.gov/Archives/edgar/data/715446/000151316218000267/0001513162-18-000267-index.htm
2019-04-24AMIT KUMARChief Executive OfficerBuy10,000.004.2742,700.00160,000.00https://www.sec.gov/Archives/edgar/data/715446/000151316219000111/0001513162-19-000111-index.htm
2019-04-26AMIT KUMARChief Executive OfficerBuy4,000.004.2116,840.00164,000.00https://www.sec.gov/Archives/edgar/data/715446/000151316219000114/0001513162-19-000114-index.htm
2019-09-13AMIT KUMARChief Executive OfficerBuy10,000.004.1241,200.00174,000.00https://www.sec.gov/Archives/edgar/data/715446/000151316219000206/0001513162-19-000206-index.htm
2020-01-14AMIT KUMARChief Executive OfficerBuy20,000.002.9959,800.00194,000.00https://www.sec.gov/Archives/edgar/data/715446/000151316220000015/0001513162-20-000015-index.htm
2019-04-29David CavalierDirectorBuy2,000.004.218,420.002,000.00https://www.sec.gov/Archives/edgar/data/715446/000151316219000115/0001513162-19-000115-index.htm
2020-01-17Arnold M BaskiesDirectorBuy10,000.003.5335,300.0021,000.00https://www.sec.gov/Archives/edgar/data/715446/000151316220000022/0001513162-20-000022-index.htm
2020-03-12AMIT KUMARChief Executive OfficerBuy20,000.001.8236,400.00214,000.00https://www.sec.gov/Archives/edgar/data/715446/000151316220000047/0001513162-20-000047-index.htm
2018-09-18Michael CatelaniCOO & CFOBuy2,250.004.4510,012.502,250.00https://www.sec.gov/Archives/edgar/data/715446/000151316218000238/0001513162-18-000238-index.htm
2020-06-12AMIT KUMARChief Executive OfficerBuy20,000.002.0340,600.00234,000.00https://www.sec.gov/Archives/edgar/data/715446/000151316220000123/0001513162-20-000123-index.htm
2018-04-09RICHARD H WILLIAMSDirectorSell25,000.004.64116,000.0025,000.00https://www.sec.gov/Archives/edgar/data/715446/000151316218000096/0001513162-18-000096-index.htm
2020-09-11AMIT KUMARChief Executive OfficerBuy28,000.002.1159,080.00262,000.00https://www.sec.gov/Archives/edgar/data/715446/000149315220017605/0001493152-20-017605-index.htm
2020-03-06Arnold M BaskiesDirectorBuy10,000.002.7127,100.0031,000.00https://www.sec.gov/Archives/edgar/data/715446/000151316220000042/0001513162-20-000042-index.htm
2020-03-12Arnold M BaskiesDirectorBuy10,000.001.8418,400.0041,000.00https://www.sec.gov/Archives/edgar/data/715446/000151316220000048/0001513162-20-000048-index.htm
2019-04-29JOHN J MONAHANDirectorBuy900.004.223,798.0050,900.00https://www.sec.gov/Archives/edgar/data/715446/000151316219000116/0001513162-19-000116-index.htm
2018-09-14Lewis H jr TittertonDirectorBuy5,000.003.9819,900.00839,544.00https://www.sec.gov/Archives/edgar/data/715446/000151316218000234/0001513162-18-000234-index.htm
2018-10-25Lewis H jr TittertonDirectorBuy2,000.004.058,100.00841,544.00https://www.sec.gov/Archives/edgar/data/715446/000151316218000269/0001513162-18-000269-index.htm
2019-04-22Lewis H jr TittertonDirectorBuy50,000.004.09204,500.00891,544.00https://www.sec.gov/Archives/edgar/data/715446/000151316219000110/0001513162-19-000110-index.htm
2019-09-13Lewis H jr TittertonDirectorBuy15,000.004.1061,500.00906,544.00https://www.sec.gov/Archives/edgar/data/715446/000151316219000207/0001513162-19-000207-index.htm
2020-01-14Lewis H jr TittertonDirectorBuy7,400.003.2223,828.00913,944.00https://www.sec.gov/Archives/edgar/data/715446/000151316220000018/0001513162-20-000018-index.htm
2020-01-15Lewis H jr TittertonDirectorBuy5,000.003.3216,600.00918,944.00https://www.sec.gov/Archives/edgar/data/715446/000151316220000019/0001513162-20-000019-index.htm
2020-03-13Lewis H jr TittertonDirectorBuy5,799.002.1212,293.88924,743.00https://www.sec.gov/Archives/edgar/data/715446/000151316220000054/0001513162-20-000054-index.htm
2020-06-15Lewis H jr TittertonDirectorBuy31,083.002.2770,558.41955,826.00https://www.sec.gov/Archives/edgar/data/715446/000151316220000124/0001513162-20-000124-index.htm
2020-06-16Lewis H jr TittertonDirectorBuy24,500.002.2755,615.00980,326.00https://www.sec.gov/Archives/edgar/data/715446/000151316220000127/0001513162-20-000127-index.htm